Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

3.0K
3.0K
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

4.7K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.7K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

2.6K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.6K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

2.9K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.9K
Viral Recombination00:57

Viral Recombination

22.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
22.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.

Journal of ginseng research·2026
Same author

Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity.

The Journal of clinical investigation·2026
Same author

GSH as an A-A Type Allosteric Activator of PKM2: Modulating Cancer Cell Homeostasis and Ferroptosis Susceptibility.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator.

Journal of biomedical science·2025
Same author

Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.

medRxiv : the preprint server for health sciences·2025
Same author

Exercise-induced MyoD mRNA Expression in Young and Older Human Skeletal Muscle: A Systematic Review and Meta-Analysis.

Sports medicine (Auckland, N.Z.)·2025

Related Experiment Video

Updated: Apr 23, 2026

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

919

SUMO and KSHV Replication.

Pei-Ching Chang1, Hsing-Jien Kung2

  • 1Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 112, Taiwan. pcchang@ym.edu.tw.

Cancers
|October 1, 2014
PubMed
Summary

Kaposi's sarcoma-associated herpesvirus (KSHV) manipulates Small Ubiquitin-related MOdifier (SUMO) pathways to control viral replication and evade host defenses. Targeting SUMOylation offers a potential therapeutic strategy against KSHV and other oncogenic herpesviruses.

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.1K
Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells
06:21

Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

12.0K

Related Experiment Videos

Last Updated: Apr 23, 2026

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

919
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

12.1K
Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells
06:21

Quantitative Fluorescence In Situ Hybridization FISH and Immunofluorescence IF of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

12.0K

Area of Science:

  • Virology
  • Molecular Biology
  • Cellular Biology

Background:

  • Small Ubiquitin-related MOdifier (SUMO) modification regulates key cellular processes like DNA repair and transcription.
  • SUMOylation is crucial for chromatin organization and plays a role in viral pathogenesis.
  • Kaposi's sarcoma-associated herpesvirus (KSHV) utilizes SUMO modification to manage viral chromatin and overcome host antiviral responses.

Purpose of the Study:

  • To elucidate the mechanisms by which KSHV exploits and regulates the host SUMO system.
  • To investigate the role of SUMOylation in KSHV's life cycle and pathogenesis.
  • To explore therapeutic strategies targeting SUMOylation in KSHV infections.

Main Methods:

  • Review of existing literature on KSHV and SUMOylation.
  • Analysis of viral proteins involved in SUMO regulation (K-bZIP, K-Rta).
  • Examination of SUMOylation's impact on viral replication and host immune evasion.

Main Results:

  • KSHV encodes proteins with SUMO ligase and SUMO-targeting ubiquitin ligase activities.
  • KSHV actively modulates the cellular SUMO environment through viral proteins.
  • SUMOylation of viral proteins and modulation by viral kinases (Orf36) are critical for KSHV replication.
  • KSHV disassembles promyelocytic leukemia protein-nuclear bodies (PML-NBs) via SUMO regulation to facilitate infection.

Conclusions:

  • KSHV extensively manipulates the host SUMO system for its own benefit during infection.
  • SUMOylation is a critical factor in KSHV's ability to replicate and cause disease.
  • Targeting viral SUMOylation pathways presents a promising therapeutic avenue for KSHV and related viruses.